Skip to main content
OpenTrials

Clinical trial condition

Acquired Immunodeficiency Syndrome

Explore clinical trials studying Acquired Immunodeficiency Syndrome. Study availability and eligibility vary by location and protocol.

137 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Acquired Immunodeficiency Syndrome trial results

Completed

Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women

NCT01705574

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • University of Southern California AIDS Clinical Trials Group Los Angeles, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • Whitman-Walker Health Washington D.C., District of Columbia, United States
  • George Washington University Medical Faculty Associates Washington D.C., District of Columbia, United States
View all 99 locations
View Trial Details
Completed

Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

NCT01497899

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States
  • Spectrum Medical Group Phoenix, Arizona, United States
  • AHF Research Center Beverly Hills, California, United States
  • Kaiser Permanente Los Angeles, California, United States
View all 41 locations
View Trial Details
Completed

Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults

NCT01967940

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Midway Immunology and Research center Ft. Pierce, Florida, United States
  • Triple O Research Institute, P.A. West Palm Beach, Florida, United States
  • Rowan Tree Medical, P.A. Wilton Manors, Florida, United States
  • Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
View all 15 locations
View Trial Details
Completed

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

NCT01968551

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Pueblo Family Physicians, Ltd. Phoenix, Arizona, United States
  • Pacific Oaks Medical Group Beverly Hills, California, United States
  • Kaiser Permanente Hayward, California, United States
  • Long Beach Education and Research Consultants Long Beach, California, United States
View all 62 locations
View Trial Details
Completed

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

NCT01721109

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • East Bay AIDS Center Medical Group Oakland, California, United States
  • University of South Florida - Department of Pediatrics Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • New York University School of Medicine New York, United States
View all 18 locations
View Trial Details

Related conditions